Pharming Group N.V. - stock earnings
PHAR Quarterly earnings
Date | Earnings | Revenue |
---|---|---|
2023Q4 | -2.7 million USD | 81.9 million USD |
2023Q3 | 3.5 million USD | 66.7 million USD |
2023Q2 | 1.3 million USD | 54.9 million USD |
2023Q1 | -12.2 million USD | 42.5 million USD |
2022Q4 | -14.6 million USD | 54.6 million USD |
2022Q3 | 9.1 million USD | 54.2 million USD |
2022Q2 | 15.7 million USD | 50.1 million USD |
2022Q1 | 1.9 million USD | 45.7 million USD |
2021Q4 | 1.9 million USD | 45.7 million USD |
2021Q3 | -272000 USD | 44.6 million USD |
2021Q2 | 5.9 million USD | 49.7 million USD |
2021Q1 | 10.6 million USD | 70.2 million USD |
2020Q4 | 10.6 million USD | 70.2 million USD |
2020Q3 | 9.6 million USD | 58.5 million USD |
2020Q2 | 11.1 million USD | 45.3 million USD |
2020Q1 | 9.3 million USD | 54.4 million USD |
2019Q4 | 14.2 million USD | 54.4 million USD |
2019Q3 | 10.9 million USD | 46.4 million USD |
2019Q2 | 7.9 million USD | 49.1 million USD |
2019Q1 | 7.6 million USD | 39.6 million USD |
2018Q4 | 15.0 million USD | 40.4 million USD |
2018Q3 | 6.3 million USD | 45.5 million USD |
2018Q2 | 3.2 million USD | 32.4 million USD |
2018Q1 | 4.1 million USD | 36.3 million USD |
2017Q4 | -51.6 million USD | 40.9 million USD |
2017Q3 | -9.7 million USD | 31.6 million USD |
2017Q2 | -28.4 million USD | 18.5 million USD |
2017Q1 | -6.1 million USD | 16.5 million USD |
2016Q4 | -6.7 million USD | 6.9 million USD |
2016Q3 | -4.2 million USD | 3.9 million USD |
2016Q2 | -3.7 million USD | 3.4 million USD |
2016Q1 | -3.8 million USD | 2.5 million USD |
2015Q4 | -4.2 million USD | 2.3 million USD |
2015Q3 | -2.7 million USD | 3.7 million USD |
2015Q2 | -2.5 million USD | 3.9 million USD |
2015Q1 | -1.4 million USD | 1.9 million USD |
2014Q4 | 16.9 million USD | 20.9 million USD |
2014Q3 | 3.5 million USD | 1.4 million USD |
2014Q2 | -5.4 million USD | 1.5 million USD |
2014Q1 | -22.1 million USD | 2.0 million USD |
2013Q4 | -5.8 million USD | 1.4 million USD |
2013Q3 | -5.6 million USD | 1.7 million USD |
2013Q2 | -2.4 million USD | 5.8 million USD |
2013Q1 | -7.0 million USD | 619813 USD |
2012Q4 | -814495 USD | 11.1 million USD |
2012Q3 | -10.1 million USD | 653268 USD |
2012Q2 | -12.3 million USD | 1.1 million USD |
2012Q1 | -8.7 million USD | 1.2 million USD |
2011Q4 | -4.1 million USD | 969612 USD |
2011Q3 | -6.6 million USD | 1.0 million USD |
2011Q2 | -6.5 million USD | 999961 USD |
2011Q1 | -5.1 million USD | 897975 USD |
2010Q4 | -27.8 million USD | -151010 USD |
2010Q3 | -9.0 million USD | 361143 USD |
2010Q2 | -23.8 million USD | 215599 USD |
2010Q1 | -10.3 million USD | 277893 USD |
2009Q4 | -12.1 million USD | 792724 USD |
2009Q3 | -11.7 million USD | 267974 USD |
2009Q2 | -12.9 million USD | 350266 USD |
2009Q1 | -8.2 million USD | 137976 USD |
PHAR Yearly earnings
Date | Earnings | Revenue |
---|---|---|
2023 | -22.1 million USD | 218.7 million USD |
2022 | 13.7 million USD | 205.6 million USD |
2021 | 16.0 million USD | 189.9 million USD |
2020 | 37.7 million USD | 228.4 million USD |
2019 | 40.5 million USD | 189.3 million USD |
2018 | 28.6 million USD | 154.6 million USD |
2017 | -95.9 million USD | 107.5 million USD |
2016 | -18.4 million USD | 16.7 million USD |
2015 | -10.9 million USD | 11.8 million USD |
2014 | -7.0 million USD | 25.8 million USD |
2013 | -20.8 million USD | 9.5 million USD |
2012 | -31.9 million USD | 14.0 million USD |
2011 | -22.2 million USD | 3.9 million USD |
2010 | -75.0 million USD | 762069 USD |
2009 | -45.9 million USD | 1.6 million USD |
2008 | -36.5 million USD | 924353 USD |
2007 | -51.9 million USD | 1.0 million USD |
2006 | -24.4 million USD | 194010 USD |
2005 | -21.2 million USD | 479681 USD |
PHAR
Price: $10.45
52 week price:
Earnings Per Share: -0.33 USD
P/E Ratio: -40.74
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 1500
Market Capitalization: 713.0 million
Average Dividend Frequency: 1